Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum

Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum

Therapeutic strategies for early-stage non-small cell lung cancer (NSCLC) are advancing, with immune checkpoint inhibitors (ICIs) and targeted therapies making their way into neoadjuvant and adjuvant settings. With recent advances, there was a need for multidisciplinary lung cancer healthcare provid...

Full description

Saved in:
Bibliographic Details
Main Authors: Parneet K. Cheema, Paul F. Wheatley-Price, Matthew J. Cecchini, Peter M. Ellis, Alexander V. Louie, Sara Moore, Brandon S. Sheffield, Jonathan D. Spicer, Patrick James Villeneuve, Natasha B. Leighl
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Current Oncology
Subjects:
early-stage non-small cell lung cancer (NSCLC)
neoadjuvant NSCLC
adjuvant NSCLC
programmed death ligand 1 (PD-L1)
epidermal growth factor receptor (EGFR)
anaplastic lymphoma kinase (ALK)
Online Access:https://www.mdpi.com/1718-7729/31/11/514
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1718-7729/31/11/514

Similar Items